REZOLUTE INC
RZLT · NASDAQ
Updated at 2026-10-15 10:31:47
- Today's High
- $4.70
- Today’s Low
- $4.21
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.52
- Previous Close
- $4.23
- Volume
- 1.69M
- Market Cap
- $409.16M
- P/E Ratio
- --
- EPS
- $-0.74
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 275 SHORELINE DRIVE, REDWOOD CITY, CA, UNITED STATES, 94065
- Country
- US
- Listing Date
- 2011-12-23
- Fiscal Year End
- June
- Shares Outstanding
- 96.29M
- CIK
- 0001509261
- Website
- www.rezolutebio.com
Rezolute, Inc., a clinical-stage biopharmaceutical company, develops rare and metabolic disease therapies in the United States. The company is headquartered in Redwood City, California.
Financial Metrics
Revenue
2026-06-30
--
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$21.56M
2026-03-31
$17.35M
2025-12-31
$24.21M
2025-09-30
$19.8M
Net Income
2026-06-30
-$20.49M
2026-03-31
-$16.17M
2025-12-31
-$22.77M
2025-09-30
-$18.15M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.20
2026-03-31
$-0.15
2025-12-31
$-0.22
2025-09-30
$-0.18
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$21.56M
2026-03-31
-$16.16M
2025-12-31
-$22.76M
2025-09-30
-$18.14M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | -- | $0 | $0 | $0 |
| Operating Expenses | $21.56M | $17.35M | $24.21M | $19.8M |
| Net Income | -$20.49M | -$16.17M | -$22.77M | -$18.15M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.20 | $-0.15 | $-0.22 | $-0.18 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$21.56M | -$16.16M | -$22.76M | -$18.14M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.